Cholangiocarcinomas Not Yet Recruiting Phase 2 Trials for Trastuzumab (DB00072)

Also known as: Cholangiocarcinoma / Cholangiocarcinoma NOS / Cholangiocarcinoma of biliary tract

IndicationStatusPhase
DBCOND0051818 (Cholangiocarcinomas)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03613168Trastuzumab in HER2-positive Biliary Tract CancerTreatment